Pro Medicus Ltd
ASX:PME

Watchlist Manager
Pro Medicus Ltd Logo
Pro Medicus Ltd
ASX:PME
Watchlist
Price: 276.81 AUD 1% Market Closed
Market Cap: 28.9B AUD
Section:
Relative Value
Relative Value
Valuation Multiples
Multiples Across Competitors
See Also

Relative Value

The Relative Value of one PME stock under the Base Case scenario is 25.51 AUD. Compared to the current market price of 276.81 AUD, Pro Medicus Ltd is Overvalued by 91%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

PME Relative Value
Base Case
25.51 AUD
Overvaluation 91%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

151.6
P/S
P/S
Price to Sales
151.6
vs History
4
vs Industry
2
Median 3Y
68.5
Median 5Y
68.5
Industry
2.2
Forward
129.3
More Details
294.3
P/E
P/E
Price to Earnings
294.3
vs History
4
vs Industry
1
Median 3Y
143.6
Median 5Y
144.5
Industry
21.7
Forward
250.7
More Details
284.4
P/OCF
P/OCF
Price to OCF
284.4
vs History
4
vs Industry
1
Median 3Y
140.2
Median 5Y
137.2
Industry
13.9
More Details
307.2
P/FCFE
P/FCFE
Price to FCFE
307.2
vs History
4
vs Industry
2
Median 3Y
156.7
Median 5Y
156.7
Industry
19.7
More Details
130.2
P/B
P/B
Price to Book Value
130.2
vs History
4
vs Industry
0
Median 3Y
62.9
Median 5Y
62.8
Industry
2.1
More Details
150.6
EV/S
EV/S
Enterprise Value to Sales
150.6
vs History
4
vs Industry
2
Median 3Y
67.6
Median 5Y
67.6
Industry
2.3
Forward
128.5
More Details
150.8
EV/GP
EV/GP
Enterprise Value to Gross Profit
150.8
vs History
4
vs Industry
2
Median 3Y
67.8
Median 5Y
67.8
Industry
4.8
More Details
205.8
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
205.8
vs History
4
vs Industry
1
Median 3Y
99.3
Median 5Y
104.9
Industry
11.4
Forward
167
More Details
205.8
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
205.8
vs History
4
vs Industry
2
Median 3Y
99.3
Median 5Y
104.9
Industry
15.4
Forward
182.1
More Details
282.6
EV/OCF
EV/OCF
Enterprise Value to OCF
282.6
vs History
4
vs Industry
1
Median 3Y
138.4
Median 5Y
135.7
Industry
13.7
More Details
303.9
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
303.9
vs History
4
vs Industry
2
Median 3Y
153.1
Median 5Y
153.1
Industry
17.2
More Details
258.3
EV/IC
EV/IC
Enterprise Value to IC
258.3
vs History
3
vs Industry
0
Median 3Y
112.5
Median 5Y
88.1
Industry
1.8
More Details

Multiples Across Competitors

PME Competitors Multiples
Pro Medicus Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
Market Cap P/S P/E EV/EBITDA EV/EBIT
AU
Pro Medicus Ltd
ASX:PME
28.9B AUD 151.6 294.3 205.8 205.8
US
Veeva Systems Inc
NYSE:VEEV
45.5B USD 15.9 58.3 48.7 51.3
US
Cerner Corp
LSE:0R00
31.3B USD 5.4 53.1 21.9 43.2
US
Doximity Inc
NYSE:DOCS
10.8B USD 19 48.5 41.2 43.1
JP
M3 Inc
TSE:2413
1.4T JPY 4.8 33.4 19 22.8
US
Waystar Holding Corp
NASDAQ:WAY
6.5B USD 6.7 250 22.8 48.8
SE
Sectra AB
STO:SECT B
60.5B SEK 29.2 107.3 -132.1 -132.1
US
Inspire Medical Systems Inc
NYSE:INSP
3.9B USD 4.6 58 59.6 70
IN
Inventurus Knowledge Solutions Ltd
NSE:IKS
270B INR 0 0 0 0
US
Vocera Communications Inc
F:V00
2.4B EUR 11.8 -325.2 265.5 4 250.6
CN
Winning Health Technology Group Co Ltd
SZSE:300253
19.1B CNY 7.3 249.8 85.8 85.8
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
AU
Pro Medicus Ltd
ASX:PME
Average EV/EBITDA: 85.6
205.8
38%
5.4
US
Veeva Systems Inc
NYSE:VEEV
48.7
38%
1.3
US
C
Cerner Corp
LSE:0R00
21.9
N/A N/A
US
Doximity Inc
NYSE:DOCS
41.2
21%
2
JP
M3 Inc
TSE:2413
19
13%
1.5
US
W
Waystar Holding Corp
NASDAQ:WAY
22.8
18%
1.3
SE
Sectra AB
STO:SECT B
Negative Multiple: -132.1 N/A N/A
US
Inspire Medical Systems Inc
NYSE:INSP
59.6
90%
0.7
IN
I
Inventurus Knowledge Solutions Ltd
NSE:IKS
Not Available N/A N/A
US
V
Vocera Communications Inc
F:V00
265.5
N/A N/A
CN
Winning Health Technology Group Co Ltd
SZSE:300253
85.8
48%
1.8
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
AU
Pro Medicus Ltd
ASX:PME
Average EV/EBIT: 535.7
205.8
36%
5.7
US
Veeva Systems Inc
NYSE:VEEV
51.3
39%
1.3
US
C
Cerner Corp
LSE:0R00
43.2
N/A N/A
US
Doximity Inc
NYSE:DOCS
43.1
22%
2
JP
M3 Inc
TSE:2413
22.8
N/A N/A
US
W
Waystar Holding Corp
NASDAQ:WAY
48.8
40%
1.2
SE
Sectra AB
STO:SECT B
Negative Multiple: -132.1 N/A N/A
US
Inspire Medical Systems Inc
NYSE:INSP
70
64%
1.1
IN
I
Inventurus Knowledge Solutions Ltd
NSE:IKS
Not Available N/A N/A
US
V
Vocera Communications Inc
F:V00
4 250.6
N/A N/A
CN
Winning Health Technology Group Co Ltd
SZSE:300253
85.8
47%
1.8

See Also

Summary
PME intrinsic value, competitors valuation, and company profile.
DCF Valuation
PME stock valuation using Discount Cash Flow valuation method.
Relative Valuation
PME stock valuation using valuation multiples.
Wall Street Estimates
PME price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
PME stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 262,900+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.